Germany-based biotech company Evotec has raised $150M to invest in new drug discovery and gene therapy.
The European Investment Bank led the funding round.
- This funding round is structured as debt.
- Evotec stated that it will use the funding to boost its R&D research process and build a manufacturing plant located in Toulouse, France.
- This funding amount will be deployed over a period of three years.
- The company also has the backing of the Government of France, in addition to being supported by multiple municipalities and regions.
- Founded in 1993, the company has over 4,500 employees in six countries.
- Since its inception, Evotec has raised nearly $740M.
